ANI Pharmaceuticals director Walsh has executed a sale of company stock valued at $1.13 million. The transaction involved a significant number of shares, reflecting a strategic financial decision by the director. This sale is part of Walsh's ongoing management of personal investment portfolios and comes amid the company's operational activities. Details regarding the specific number of shares sold and the timing of the transaction have not been disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.